Prestige Consumer Healthcare, Inc. (PBH)
52.01
+0.70
(+1.36%)
USD |
NYSE |
Aug 24, 16:00
52.01
0.00 (0.00%)
After-Hours: 20:00
Prestige Consumer Healthcare Net Income (Quarterly) : 29.18M for June 30, 2026
Net Income (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 29.18M |
| March 31, 2026 | 53.93M |
| December 31, 2025 | 46.70M |
| September 30, 2025 | 42.21M |
| June 30, 2025 | 47.47M |
| March 31, 2025 | 50.13M |
| December 31, 2024 | 61.03M |
| September 30, 2024 | 54.38M |
| June 30, 2024 | 49.07M |
| March 31, 2024 | 49.46M |
| December 31, 2023 | 53.05M |
| September 30, 2023 | 53.56M |
| June 30, 2023 | 53.28M |
| March 31, 2023 | -240.55M |
| December 31, 2022 | 51.95M |
| September 30, 2022 | 51.02M |
| June 30, 2022 | 55.27M |
| March 31, 2022 | 52.09M |
| December 31, 2021 | 50.22M |
| September 30, 2021 | 45.32M |
| June 30, 2021 | 57.76M |
| March 31, 2021 | 35.51M |
| December 31, 2020 | 40.87M |
| September 30, 2020 | 44.59M |
| June 30, 2020 | 43.71M |
| Date | Value |
|---|---|
| March 31, 2020 | 37.05M |
| December 31, 2019 | 38.06M |
| September 30, 2019 | 33.25M |
| June 30, 2019 | 33.92M |
| March 31, 2019 | -139.27M |
| December 31, 2018 | 38.17M |
| September 30, 2018 | 30.84M |
| June 30, 2018 | 34.47M |
| March 31, 2018 | -39.69M |
| December 31, 2017 | 314.79M |
| September 30, 2017 | 30.70M |
| June 30, 2017 | 33.76M |
| March 31, 2017 | 11.09M |
| December 31, 2016 | 31.64M |
| September 30, 2016 | 32.20M |
| June 30, 2016 | -5.531M |
| March 31, 2016 | 13.94M |
| December 31, 2015 | 28.00M |
| September 30, 2015 | 31.80M |
| June 30, 2015 | 26.17M |
| March 31, 2015 | 23.77M |
| December 31, 2014 | 21.29M |
| September 30, 2014 | 16.46M |
| June 30, 2014 | 16.73M |
| March 31, 2014 | 16.00M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Indivior Pharmaceuticals, Inc. | 122.00M |
| ANI Pharmaceuticals, Inc. | 23.00M |
| Corcept Therapeutics, Inc. | 42.14M |
| Veru, Inc. | -6.988M |
| Johnson & Johnson | 5.534B |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 265.71M |
| Total Expenses (Quarterly) | 236.53M |
| EPS Diluted (Quarterly) | 0.6129 |
| Enterprise Value | 4.409B |
| Gross Profit Margin (Quarterly) | 49.11% |
| Profit Margin (Quarterly) | 10.98% |
| Earnings Yield | 6.87% |
| Operating Earnings Yield | 11.58% |
| Normalized Earnings Yield | 6.867 |